硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 RALGAPA1 抗体对
试剂盒

抗人 RALGAPA1 抗体对

01AB01322

Ral GTPase activating protein catalytic subunit alpha 1 (RALGAPA1) is a key component of the RalGAP complex, which regulates the activity of RalA and RalB, small GTPases involved in intracellular vesicle trafficking, cell migration, and cytoskeletal dynamics. This protein exhibits GTPase activator activity, converting Ral proteins from their active GTP-bound state to an inactive GDP-bound form. RALGAPA1 functions as the catalytic subunit of the heterodimeric RalGAP complex, alongside a scaffolding β subunit, and plays a crucial role in maintaining cellular signaling balance. Dysregulation of RALGAPA1 can lead to constitutive activation of RalA, disrupting processes such as neuronal polarity and brain development. Mutations or deficiencies in RALGAPA1 are associated with profound neurodevelopmental disabilities, muscular hypotonia, infantile spasms, and feeding abnormalities. Additionally, reduced expression of RALGAPA1 has been linked to enhanced malignancy in cancers like pancreatic ductal adenocarcinoma due to increased migratory and invasive capacities of tumor cells.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
RALGAPA1
基因别名
GARNL1; KIAA0884; TULIP1
蛋白别名
Ral GTPase activating protein catalytic subunit alpha 1; RALGAPA1
UniProt
Q6GYQ0
物种
Human

产品详情

靶点名称
RALGAPA1
蛋白名称
Ral GTPase activating protein catalytic subunit alpha 1
蛋白别名
Ral GTPase-activating protein subunit alpha-1; GAP-related-interacting partner to E12; GRIPE; GTPase-activating Rap/Ran-GAP domain-like 1; Tuberin-like protein 1; p240
靶点基因名
RALGAPA1
基因别名
GARNL1; KIAA0884; TULIP1
UniProt
Q6GYQ0
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Ral GTPase activating protein catalytic subunit alpha 1 (RALGAPA1) is a key component of the RalGAP complex, which regulates the activity of RalA and RalB, small GTPases involved in intracellular vesicle trafficking, cell migration, and cytoskeletal dynamics. This protein exhibits GTPase activator activity, converting Ral proteins from their active GTP-bound state to an inactive GDP-bound form. RALGAPA1 functions as the catalytic subunit of the heterodimeric RalGAP complex, alongside a scaffolding β subunit, and plays a crucial role in maintaining cellular signaling balance. Dysregulation of RALGAPA1 can lead to constitutive activation of RalA, disrupting processes such as neuronal polarity and brain development. Mutations or deficiencies in RALGAPA1 are associated with profound neurodevelopmental disabilities, muscular hypotonia, infantile spasms, and feeding abnormalities. Additionally, reduced expression of RALGAPA1 has been linked to enhanced malignancy in cancers like pancreatic ductal adenocarcinoma due to increased migratory and invasive capacities of tumor cells.